Medpace Holdings, Inc. (MEDP) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	2.8B	2.5B	2.1B	1.9B	1.5B
Cost of Revenue	2.0B	1.8B	1.5B	1.4B	1.0B
Gross Profit	800.2M	760.6M	656.3M	524.5M	432.4M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	189.0M	197.6M	180.2M	161.4M	131.4M
General & Admin Expense	—	—	178.7M	—	—
Selling & Marketing Expense	—	—	1.5M	—	—
Other Expenses	27.8M	28.1M	29.3M	26.3M	22.3M
Total Operating Expenses	216.8M	225.7M	209.4M	187.7M	153.7M
Cost and Expenses	2.2B	2.0B	1.7B	1.5B	1.2B
Operating Income (EBIT)	583.4M	534.9M	446.9M	336.8M	278.7M
Non-Operating
Interest Income	1.5M	—	25.0M	—	—
Interest Expense	—	—	—	488.0K	2.9M
Net Interest Income	1.5M	—	25.0M	(488.0K)	(2.9M)
Other Non-Op Income/Expense	15.5M	7.4M	29.1M	(1.1M)	4.2M
Non-Operating Income (excl Interest)	(4.6M)	(7.4M)	(29.1M)	655.0K	(7.1M)
EBT (Pre-Tax Income)	598.9M	542.4M	475.9M	335.7M	282.9M
Income Tax Expense	107.4M	91.3M	71.5M	52.9M	37.5M
Bottom Line
Net Income	491.5M	451.1M	404.4M	282.8M	245.4M
Earnings from Cont. Ops	491.5M	451.1M	404.4M	282.8M	245.4M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	491.5M	451.1M	404.3M	282.6M	245.2M
Per Share
Basic EPS	$17.39	$15.64	$13.06	$9.20	$7.57
Diluted EPS	$17.07	$15.28	$12.63	$8.88	$7.28
Revenue Per Share	$98.29	$87.72	$68.13	$61.38	$45.08
Shares
Basic Shares Outstanding	28.3M	28.8M	31.0M	30.7M	32.4M
Diluted Shares Outstanding	28.8M	29.5M	32.0M	31.8M	33.7M
Profitability Metrics
EBITDA	602.2M	570.5M	505.2M	362.5M	308.1M
D&A	14.2M	28.1M	29.3M	26.3M	22.3M
EBIT	588.0M	542.4M	475.9M	336.2M	285.8M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026